{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T01:18:38Z","timestamp":1773451118486,"version":"3.50.1"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"siue school of pharmacy research grants"},{"name":"siue internal awards"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Artificial pancreas system (APS) is an emerging new treatment for type 1 diabetes mellitus. The aim of this study was to develop a rat APS as a research tool and demonstrate its application. We established a rat APS using Medtronic Minimed Pump 722, Medtronic Enlite sensor, and the open artificial pancreas system as a controller. We tested different dilutions of Humalog (100 units\/ml) in saline ranged from 1:3 to 1:20 and determined that 1:7 dilution works well for rats with ~500g bodyweight. Blood glucose levels (BGL) of diabetic rats fed with chow diet (58% carbohydrate) whose BGL was managed by the closed-loop APS for the total duration of 207h were in euglycemic range (70\u2013180 mg\/dl) for 94.5% of the time with 2.1% and 3.4% for hyperglycemia (&gt;180mg\/dl) and hypoglycemia (&lt;70 mg\/dl), respectively. Diabetic rats fed with Sucrose pellets (94.8% carbohydrate) for the experimental duration of 175h were in euglycemic range for 61% of the time with 35% and 4% for hyperglycemia and hypoglycemia, respectively. Heathy rats fed with chow diet showed almost a straight line of BGL ~ 95 mg\/dl (average 94.8 mg\/dl) during the entire experimental period (281h), which was minimally altered by food intake. In the healthy rats, feeding sucrose pellets caused greater range of BGL in high and low levels but still within euglycemic range (99.9%). Next, to study how healthy and diabetic rats handle supra-physiological concentrations of glucose, we intraperitoneally injected various amounts of 50% dextrose (2, 3, 4g\/kg) and monitored BGL. Duration of hyperglycemia after injection of 50% dextrose at all three different concentrations was significantly greater for healthy rats than diabetic rats, suggesting that insulin infusion by APS was superior in reducing BGL as compared to natural insulin released from pancreatic \u03b2-cells.<jats:italic>Ex vivo<\/jats:italic>studies showed that islets isolated from diabetic rats were almost completely devoid of pancreatic \u03b2-cells but with intact \u03b1-cells as expected. Lipid droplet deposition in the liver of diabetic rats was significantly lower with higher levels of triacylglyceride in the blood as compared to those of healthy rats, suggesting lipid metabolism was altered in diabetic rats. However, glycogen storage in the liver determined by Periodic acid-Schiff staining was not altered in diabetic rats as compared to healthy rats. A rat APS may be used as a powerful tool not only to study alterations of glucose and insulin homeostasis in real-time caused by diet, exercise, hormones, or antidiabetic agents, but also to test mathematical and engineering models of blood glucose prediction or new algorithms for closed-loop APS.<\/jats:p>","DOI":"10.1371\/journal.pone.0254718","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T17:26:22Z","timestamp":1626456382000},"page":"e0254718","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":7,"title":["Study of blood glucose and insulin infusion rate in real-time in diabetic rats using an artificial pancreas system"],"prefix":"10.1371","volume":"16","author":[{"given":"Omer Batuhan","family":"Kirilmaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshay Radhakrishna","family":"Salegaonkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9989-8081","authenticated-orcid":true,"given":"Justin","family":"Shiau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guney","family":"Uzun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoo Sang","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H. Felix","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2420-9277","authenticated-orcid":true,"given":"Guim","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"issue":"3\u20134","key":"pone.0254718.ref001","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/dmr.5610020301","article-title":"Pancreatic islet glucose metabolism and regulation of insulin secretion","volume":"2","author":"MD Meglasson","year":"1986","journal-title":"Diabetes Metab Rev"},{"issue":"1","key":"pone.0254718.ref002","doi-asserted-by":"crossref","first-page":"44","DOI":"10.2337\/diacare.29.01.06.dc05-1686","article-title":"Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial","volume":"29","author":"S Garg","year":"2006","journal-title":"Diabetes Care"},{"issue":"2","key":"pone.0254718.ref003","doi-asserted-by":"crossref","first-page":"70","DOI":"10.17925\/EE.2019.15.2.70","article-title":"Advances in Type 1 Diabetes Technology Over the Last Decade","volume":"15","author":"C Zimmerman","year":"2019","journal-title":"Eur Endocrinol"},{"issue":"6","key":"pone.0254718.ref004","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1210\/er.2018-00174","article-title":"Realizing a Closed-Loop (Artificial Pancreas) System for the Treatment of Type 1 Diabetes","volume":"40","author":"RA Lal","year":"2019","journal-title":"Endocr Rev"},{"issue":"10","key":"pone.0254718.ref005","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s40265-019-01149-2","article-title":"Artificial Pancreas: Current Progress and Future Outlook in the Treatment of Type 1 Diabetes","volume":"79","author":"R Ramli","year":"2019","journal-title":"Drugs"},{"issue":"4","key":"pone.0254718.ref006","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1292\/jvms.19-0450","article-title":"Effect of dapagliflozin alone and in combination with insulin in a rat model of type 1 diabetes","volume":"82","author":"N Sayed","year":"2020","journal-title":"J Vet Med Sci"},{"issue":"2","key":"pone.0254718.ref007","doi-asserted-by":"crossref","DOI":"10.3390\/nu12020382","article-title":"Metabolic and Cognitive Effects of Ranolazine in Type 2 Diabetes Mellitus: Data from an in vivo Model","volume":"12","author":"V Cassano","year":"2020","journal-title":"Nutrients"},{"issue":"3","key":"pone.0254718.ref008","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00592-019-01421-7","article-title":"Saxagliptin attenuates glomerular podocyte injury by increasing the expression of renal nephrin and podocin in type 2 diabetic rats","volume":"57","author":"Y Hu","year":"2020","journal-title":"Acta Diabetol"},{"key":"pone.0254718.ref009","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fcimb.2019.00455","article-title":"Promising Treatment for Type 2 Diabetes: Fecal Microbiota Transplantation Reverses Insulin Resistance and Impaired Islets","volume":"9","author":"H Wang","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"issue":"6","key":"pone.0254718.ref010","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2337\/db07-1472","article-title":"Dapagliflozin, a selective SGLT2 inhibitor, improves glucose homeostasis in normal and diabetic rats","volume":"57","author":"S Han","year":"2008","journal-title":"Diabetes"},{"issue":"2","key":"pone.0254718.ref011","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/dom.14258","article-title":"Add-on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream study","volume":"23","author":"T Biester","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"4","key":"pone.0254718.ref012","doi-asserted-by":"crossref","first-page":"e387","DOI":"10.1002\/ctm2.387","article-title":"Full closed loop open-source algorithm performance comparison in pigs with diabetes","volume":"11","author":"RA Lal","year":"2021","journal-title":"Clin Transl Med"},{"issue":"4","key":"pone.0254718.ref013","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1113\/expphysiol.2011.062307","article-title":"Enhanced insulin secretion and glucose tolerance in rats exhibiting low plasma free fatty acid levels and hypertriglyceridaemia due to congenital albumin deficiency","volume":"97","author":"TR Figueira","year":"2012","journal-title":"Exp Physiol"},{"issue":"6","key":"pone.0254718.ref014","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2337\/diacare.26.6.1902","article-title":"Hypoglycemia in diabetes","volume":"26","author":"PE Cryer","year":"2003","journal-title":"Diabetes Care"},{"issue":"8","key":"pone.0254718.ref015","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1007\/s00125-003-1153-1","article-title":"Insulin granule dynamics in pancreatic beta cells","volume":"46","author":"P Rorsman","year":"2003","journal-title":"Diabetologia"},{"issue":"3","key":"pone.0254718.ref016","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2337\/db15-1264","article-title":"Monitoring C-Peptide Storage and Secretion in Islet beta-Cells In Vitro and In Vivo","volume":"65","author":"S Zhu","year":"2016","journal-title":"Diabetes"},{"issue":"6","key":"pone.0254718.ref017","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4161\/isl.22720","article-title":"beta-cell metabolic alterations under chronic nutrient overload in rat and human islets","volume":"4","author":"S Vernier","year":"2012","journal-title":"Islets"},{"key":"pone.0254718.ref018","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.abb.2015.04.005","article-title":"SR-135, a peroxynitrite decomposing catalyst, enhances beta-cell function and survival in B6D2F1 mice fed a high fat diet","volume":"577\u2013578","author":"M Johns","year":"2015","journal-title":"Arch Biochem Biophys"},{"key":"pone.0254718.ref019","first-page":"181","article-title":"Streptozotocin-induced type 1 diabetes in rodents as a model for studying mitochondrial mechanisms of diabetic beta cell glucotoxicity","volume":"8","author":"J Wu","year":"2015","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"2","key":"pone.0254718.ref020","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/acta.0.0890339","article-title":"Studies on the tissue-disposition and fate of [14C]streptozotocin with special reference to the pancreatic islets","volume":"89","author":"EB Johansson","year":"1978","journal-title":"Acta Endocrinol (Copenh)"},{"issue":"6","key":"pone.0254718.ref021","doi-asserted-by":"crossref","first-page":"3059","DOI":"10.1073\/pnas.96.6.3059","article-title":"Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes","volume":"96","author":"AA Pieper","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"pone.0254718.ref022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0921-8777(00)00016-1","article-title":"Poly(ADP-ribose) polymerase-1: what have we learned from the deficient mouse model?","volume":"460","author":"S Shall","year":"2000","journal-title":"Mutat Res"},{"issue":"4","key":"pone.0254718.ref023","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1152\/physrev.00025.2004","article-title":"Regulation of pancreatic beta-cell mass","volume":"85","author":"L Bouwens","year":"2005","journal-title":"Physiol Rev"},{"issue":"4","key":"pone.0254718.ref024","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","article-title":"The interaction of hepatic lipid and glucose metabolism in liver diseases","volume":"56","author":"LP Bechmann","year":"2012","journal-title":"J Hepatol"},{"issue":"6","key":"pone.0254718.ref025","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"JD Browning","year":"2004","journal-title":"Hepatology"},{"issue":"2","key":"pone.0254718.ref026","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.26672","article-title":"Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes","volume":"59","author":"AL Birkenfeld","year":"2014","journal-title":"Hepatology"},{"key":"pone.0254718.ref027","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.abb.2016.03.002","article-title":"Oral administration of SR-110, a peroxynitrite decomposing catalyst, enhances glucose homeostasis, insulin signaling, and islet architecture in B6D2F1 mice fed a high fat diet","volume":"596","author":"M Johns","year":"2016","journal-title":"Arch Biochem Biophys"},{"issue":"5","key":"pone.0254718.ref028","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2337\/diab.28.5.472","article-title":"Synthesis and accumulation of triglycerides in liver of diabetic rats. Effects of insulin treatment","volume":"28","author":"VK Murthy","year":"1979","journal-title":"Diabetes"},{"issue":"6","key":"pone.0254718.ref029","doi-asserted-by":"crossref","first-page":"e00310","DOI":"10.1016\/j.heliyon.2017.e00310","article-title":"Estimation of insulin secretion, glucose uptake by tissues, and liver handling of glucose using a mathematical model of glucose-insulin homeostasis in lean and obese mice","volume":"3","author":"M Brenner","year":"2017","journal-title":"Heliyon"},{"issue":"1","key":"pone.0254718.ref030","doi-asserted-by":"crossref","first-page":"e03251","DOI":"10.1016\/j.heliyon.2020.e03251","article-title":"Tracking changes of the parameters of glucose-insulin homeostasis during the course of obesity in B6D2F1 mice","volume":"6","author":"S Esmaeili Mohsen Abadi","year":"2020","journal-title":"Heliyon"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0254718","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T04:45:21Z","timestamp":1699245921000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0254718"}},"subtitle":[],"editor":[{"given":"Michael","family":"Bader","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,7,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0254718","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]}}}